Stock listing

2HA Stock Price, News, Filings & Events — Spero Therapeutics, Inc.

Selected listing: 2HA · GETTEX · EUR · DE

The 2HA:GETTEX listing represents Spero Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments for bacterial infections. Recently, the company has been active in advancing its clinical programs and has made filings related to its drug candidates. Investors can stay informed about upcoming events and announcements that may impact the company's market position. Spero Therapeutics continues to navigate the competitive landscape of antibiotic development, aiming to address significant unmet medical needs.

2HA:GETTEXEURDEUpdated July 24, 2026
Spero Therapeutics, Inc. logo
Ticker
2HA:GETTEX
Asset type
Stock
Market cap
$68.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Spero Therapeutics, Inc. 2HA:GETTEX stock context

The 2HA:GETTEX listing represents Spero Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments for bacterial infections. Recently, the company has been active in advancing its clinical programs and has made filings related to its drug candidates. Investors can stay informed about upcoming events and announcements that may impact the company's market position. Spero Therapeutics continues to navigate the competitive landscape of antibiotic development, aiming to address significant unmet medical needs.

Research Spero Therapeutics, Inc.

Alternate listings